Agitation – Talk Bio

Actionable Insights Powered by AI

Otsuka Discontinues Alzheimer’s Agitation Drug Development Following Second Unsuccessful Trial

Otsuka, Alzheimer’s disease, agitation, drug development, clinical trials, failed trials, discontinuation